leisure time -WSS

leisure time

author：comprehensive 2025-09-03 11:52:15 - browse：8

Photo illustration with orange background of Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) -- biotech coverage from STAT — Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) Illustration: Christine Kao/STAT; Courtesy: Steve Shoffner & Michael Haber

After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched Wednesday with $135 million and plans to compete with Vertex Pharmaceuticals.

The startup is called Latigo Biotherapeutics, and it’s launching having already started a Phase 1 trial for a non-opioid pain medicine, LTG-001. The oral therapy is designed to silence pain-signaling neurons by blocking a sodium channel called NaV 1.8.

Westlake had set out years ago to scout out new options for pain medicines, and found a research desert, according to founding managing director Sean Harper. But NaV 1.8 has emerged as a promising option because of its potential to be non-addictive and to lessen pain without affecting a person’s central nervous system, digestion, or heart rate, as opioids can. There were still few high-quality molecules in development that could be licensed from an academic lab or another drug company, so Westlake decided to develop its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： North Korean leader's powerful sister says warplanes repelled US spy plane

WSS

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Biden will tout long

leisure time

leisure time

explore

What does generative AI mean for health care? We asked experts

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Novavax promises a turnaround & Lilly roils the obesity market

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

The cancer drug shortage isn’t new — and neither are the solutions

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Malaria cases in Florida and Texas: Here’s what you need to know

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Illinois to ban advertising for guns allegedly marketed to kids and militants

hotspot

Drinking water from half of US faucets contains PFAS: Study

NYC plans to house migrants on an island in the East River

Another man arrested in connection with shooting at Kansas nightclub

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

California man arrested in connection with serial murders of Mexican strip club workers

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Wikipedia

focus

hotspot

leisure time